Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
Paul Ehrlich Institute, Langen, Germany.
Thromb Res. 2020 Apr;188:74-78. doi: 10.1016/j.thromres.2020.02.010. Epub 2020 Feb 13.
Factor VII activating protease (FSAP) is a circulating serine protease of broad specificity that is likely to be involved in many pathophysiological processes. The activation of the circulating zymogen form of FSAP by histones, released from damaged cells, underlines its roles in regulating host responses to tissue damage and inflammation. Some of the direct cellular effects of FSAP are mediated through protease-activated receptors (PARs). Knock-down of each one of the four PARs in endothelial cells indicated that PAR-1 and -3 are involved in regulating endothelial permeability in response to FSAP. Overexpression of PARs in cell lines led to the conclusion that PAR-2 and -1 were the main receptors for FSAP. Studies with synthetic peptides and receptor mutants demonstrate that FSAP cleaves PAR-1 and -2 at their canonical cleavage site. However, PAR-1 is not activated by FSAP in all cells, which may be related to other, as yet, undefined factors. Inhibition of apoptosis by FSAP is mediated through PAR-1 and was observed in neurons, astrocytes and A549 cells. FSAP also mediates cellular effects by modulating the activity of growth factors, generation of bradykinin, C5a and C3a generation or histone inactivation. These cellular effects need to be further investigated at the in vivo level.
因子 VII 激活蛋白酶(FSAP)是一种广泛特异性的循环丝氨酸蛋白酶,可能参与许多病理生理过程。组蛋白从受损细胞中释放出来,激活 FSAP 的循环酶原形式,强调了其在调节宿主对组织损伤和炎症的反应中的作用。FSAP 的一些直接细胞效应是通过蛋白酶激活受体(PARs)介导的。在血管内皮细胞中敲低每个 PAR,表明 PAR-1 和 -3 参与调节内皮细胞对 FSAP 的通透性。在细胞系中过表达 PARs,得出结论认为 PAR-2 和 -1 是 FSAP 的主要受体。用合成肽和受体突变体进行的研究表明,FSAP 在其经典切割位点切割 PAR-1 和 -2。然而,FSAP 并不能在所有细胞中激活 PAR-1,这可能与其他尚未定义的因素有关。FSAP 通过 PAR-1 抑制细胞凋亡,在神经元、星形胶质细胞和 A549 细胞中观察到。FSAP 还通过调节生长因子的活性、缓激肽、C5a 和 C3a 的产生或组蛋白失活来介导细胞效应。这些细胞效应需要在体内水平进一步研究。